DOI QR코드

DOI QR Code

Two Cases of Toxic Epidermal Necrolysis Associated with Deflazacort Therapy in Nephrotic Syndrome: Successfully Treated with Cyclosporine A

  • Lim, Myung Hee (Department of Pediatrics, Yeungnam University Hospital, Yeungnam University College of Medicine) ;
  • Bae, Hee Jung (Department of Pediatrics, Yeungnam University Hospital, Yeungnam University College of Medicine) ;
  • Park, Sun Young (Department of Pediatrics, Yeungnam University Hospital, Yeungnam University College of Medicine) ;
  • Kim, Sae Yoon (Department of Pediatrics, Yeungnam University Hospital, Yeungnam University College of Medicine) ;
  • Park, Yong Hoon (Department of Pediatrics, Yeungnam University Hospital, Yeungnam University College of Medicine)
  • 투고 : 2016.09.13
  • 심사 : 2016.10.10
  • 발행 : 2016.10.30

초록

Toxic epidermal necrolysis (TEN) is a rare, acute, serious, and potentially fatal skin disease, in which cell death causes the epidermis to separate from the dermis. It is thought to be a hypersensitivity complex that affects the skin and mucous membranes, and is caused by certain medications, infections, genetic factors, underlying immunologic disease, or more rarely, cancers. We report two cases of TEN associated with deflazacort (DFZ), a derivative of prednisolone, used in the first episode of nephrotic syndrome (NS). The skin eruption appeared on the $4^{th}$ and $5^{th}$ weeks after DFZ administration, while NS was in remission. The widespread lesions were managed by intensive supportive treatment, discontinuation of DFZ, and oral administration of cyclosporine. Both patients showed a rapid improvement in symptoms of TEN without any complications or relapse of NS.

키워드

참고문헌

  1. Ferrandiz-Pulido C, Garcia-Patos V. A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Arch Dis Child 2013;98: 998-1003. https://doi.org/10.1136/archdischild-2013-303718
  2. Kim DW, Jung DE, Koo JW. Steroid and enalapril therapy-possible cause of toxic epidermal necrolysis. Korean J Pediatr 2006;49:332-6. https://doi.org/10.3345/kjp.2006.49.3.332
  3. Lee EC. Toxic epidermal necrolysis associated with deflazacort therapy with nephrotic syndrome. Kidney Res Clin Pract 2014;33:222-5. https://doi.org/10.1016/j.krcp.2014.08.002
  4. Wood ML, Gray RES, Kanis JA, Harrington CI. Deflazacort-a safer systemic steroid for the treatment of chronic dermatoses. Br J Dermatol 1985;113(s 29):34-5.
  5. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis 2010;5:39. https://doi.org/10.1186/1750-1172-5-39
  6. Aihara Y, Ito R, Ito S, Aihara M, Yokota S. Toxic epidermal necrolysis in a child successfully treated with cyclosporine A and methylprednisolone. Pediatr Int 2007;49:659-62. https://doi.org/10.1111/j.1442-200X.2007.02439.x
  7. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7. https://doi.org/10.1056/NEJM199512143332404
  8. Araki Y, Sotozono C, Inatomi T, Ueta M, Yokoi N, Ueda E, et al. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol 2009;147:1004-11. https://doi.org/10.1016/j.ajo.2008.12.040
  9. Hinc-Kasprzyk J, Polak-Krzeminska A, Ozog-Zabolska I. Toxic epidermal necrolysis. Anaesthesiol Intensive Ther 2015;47:257-62. https://doi.org/10.5603/AIT.2015.0037
  10. Fernando SL. The management of toxic epidermal necrolysis. Australas J Dermatol 2012;53:165-71. https://doi.org/10.1111/j.1440-0960.2011.00862.x
  11. Jat KR, Khairwa A. Deflazacort in comparison to other steroids of nephrotic syndrome. Indian J Nephrol 2012;22:239-45. https://doi.org/10.4103/0971-4065.101238
  12. Kim SY, Lee JM, Park YH. A case of steroid-induced psychosis in a child having nephrotic syndrome with toxic epidermal necrolysis. Korean J Pediatr 2010;53:437-41. https://doi.org/10.3345/kjp.2010.53.3.437
  13. Arevalo JM, Lorente JA, Gonzalez-Herrada C, Jimenez-Reyes J. Treatment of toxic epidermal necrolysis with cyclosporine A. Trauma 2000;48:473-8. https://doi.org/10.1097/00005373-200003000-00017